Powell Investment Advisors’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
VCM
VPM
Powell Investment Advisors's BMY Position: Q1 2026 in Review
Powell Investment Advisors held its Bristol-Myers Squibb (BMY) position steady in Q1 2026 at 8,653 shares worth $525K. The position accounts for 0.18% of the portfolio, ranked #78.
Powell Investment Advisors first reported a position in BMY in Q4 2019 and has held it in 26 quarters since. The position peaked at $623K in Q4 2022. 2,520 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- Powell Investment Advisors held 8,653 shares of Bristol-Myers Squibb worth $525K as of Q1 2026.
- Powell Investment Advisors left its Bristol-Myers Squibb share count unchanged in Q1 2026.
- Bristol-Myers Squibb made up 0.18% of Powell Investment Advisors's portfolio in Q1 2026, its #78 holding.
- Powell Investment Advisors first reported a position in Bristol-Myers Squibb in Q4 2019 and has held it in 26 quarters since.
- Powell Investment Advisors's Bristol-Myers Squibb position peaked at $623K in Q4 2022.
- 2,520 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on Powell Investment Advisors's 13F filing for Q1 2026, filed 23 Apr 2026.